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OBJECTIVE
Approximately one-third of the adult U.S. population has the metabolic syn-
drome. Its prevalence is the highest among Hispanic adults, but variation by
Hispanic/Latino background is unknown. Our objective was to quantify the prev-
alence of the metabolic syndrome among men and women 18–74 years of age of
diverse Hispanic/Latino background.
RESEARCH DESIGN AND METHODS
Two-stage area probability sample of households in four U.S. locales, yielding
16,319 adults (52% women) who self-identified as Cuban, Dominican, Mexican,
Puerto Rican, Central American, or South American. The metabolic syndrome was
defined according to the American Heart Association/National Heart, Lung, and
Blood Institute 2009 Joint Scientific Statement. Themain outcomemeasures were
age-standardized prevalence of the metabolic syndrome per the harmonized
American Heart Association/National Heart, Lung, and Blood Institute definition
and its component abnormalities.
RESULTS
The metabolic syndrome was present in 36% of women and 34% of men. Differ-
ences in the age-standardized prevalence were seen by age, sex, and Hispanic/
Latino background. The prevalence of the metabolic syndrome among those 18–
44, 45–64, and 65–74 years of age was 23%, 50%, and 62%, respectively, among
women; and 25%, 43%, and 55%, respectively, among men. Among women, the
metabolic syndrome prevalence ranged from 27% in South Americans to 41% in
Puerto Ricans. Among men, prevalences ranged from 27% in South Americans to
35% in Cubans. In those with the metabolic syndrome, abdominal obesity was
present in 96% of the women compared with 73% of the men; more men (73%)
than women (62%) had hyperglycemia.
CONCLUSIONS
The burden of cardiometabolic abnormalities is high in Hispanic/Latinos but varies
by age, sex, and Hispanic/Latino background. Hispanics/Latinos are thus at in-
creased, but modifiable, predicted lifetime risk of diabetes and its cardiovascular
sequelae.
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Many areas of the world experience a
high population burden ofmetabolic ab-
normalities collectively known as meta-
bolic syndrome (1). Included in this
syndrome are insulin resistance; adipos-
ity; hyperglycemia; hyperlipidemia; ele-
vated blood pressure; and a sustained,
mild proinflammatory profile (1). Over
the past decade, heavier U.S. adults
have gained more adiposity, and ethnic
disparities in BMI and waist circumfer-
ence have grown (2). BMI in men and
women, as well as waist circumference
in men, increased linearly, but among
women waist circumference increased
at a steeper rate at higher percentile
values (2).
In the context of a widespread obesity
epidemic, the cardiometabolic abnor-
malities associated with excess weight
and ectopic fat deposition are of consid-
erable clinical and public health interest
(3) since the metabolic syndrome con-
fers an elevated risk of the development
of type 2 diabetes and cardiovascular
sequelae, and mortality (4–6). Based
on a recently harmonized definition of
the metabolic syndrome (7), the age-
adjusted prevalence of metabolic syn-
drome in the U.S. is between 34 and
39%, depending on the thresholds
used to define abdominal adiposity.
The highest prevalence of the metabolic
syndrome in the U.S. was observed
among Mexican Americans in the Na-
tional Health and Nutrition Examination
Survey (NHANES), 1988–1994 (8). In this
report, we provide estimates of the
prevalence of the metabolic syndrome
among U.S. Hispanic/Latino individuals
who were 18–74 years of age, were
from different Hispanic backgrounds,
and were recruited from randomly se-
lected households in 4 of the 10 largest
Hispanic/Latino urban U.S. communities
by the Hispanic Community Health
Study/Study of Latinos (HCHS/SOL).
RESEARCH DESIGN AND METHODS
The National Institutes of Health–
supported HCHS/SOL was designed to
examine the prevalence of risk factors
and protective factors for chronic dis-
eases, and their association with the in-
cidence of newly developed disease
among Hispanic/Latinos (http://www
.cscc.unc.edu/hchs/). The HCHS/SOL de-
sign and sampling methods have been
published (9). Between March 2008
and June 2011, 16,415 self-identified
Hispanic/Latino persons 18–74 years of
age were recruited from randomly se-
lected households in the Bronx, New
York; San Diego, California; Chicago, Illi-
nois; and Miami, Florida. The study was
designed to include participants from
Cuban, Dominican, Mexican, Puerto
Rican, Central American, and South Amer-
ican backgrounds in pre-established
proportions. Households were chosen
using a stratified two-stage area proba-
bility sample design. Census block
groups were randomly selected in spec-
ified geographic areas of each study site,
and households were randomly selected
in each sample block group. Households
were screened for eligibility, and self-
identified Hispanic/Latino persons 18–
74 years of age were selected in each
household. Oversampling occurred at
each stage (block groups in areas of
high concentration of Hispanic/Latinos,
households associated with an Hispanic/
Latino surname, and persons 45–74 years
of age at were sampled at rates higher
than younger household members).
Sampling weights that reflect the prob-
abilities of selection at each stage were
used in the statistical analyses. Approval
by institutional review boards was ob-
tained at each participating institution,
and written informed consent was ob-
tained from all study participants.
Study Measurements
All examinations and interviewer-
administered questionnaires were con-
ducted by centrally trained and certified
study personnel following a standard-
ized protocol, which included ongoing
quality assurance procedures. All study
protocolmanuals are available at http://
www.cscc.unc.edu/hchs/. Study partici-
pants were asked to fast and to abstain
from smoking 12 h prior to the exami-
nation and also to avoid vigorous phys-
ical activity on the morning of the
examination. Body weight was mea-
sured to the nearest 0.1 kg, and height
was recorded to the nearest centimeter.
Abdominal girth was measured in dupli-
cate using standardized reference
points. Three seated blood pressure
measurements were obtained after a
5-min rest using an oscillometric auto-
mated sphygmomanometer. The average
of the second and third measurements
was used in these analyses.
Blood samples were obtained following
a nontraumatic venipuncture protocol;
fresh as well as frozen specimens were
shipped to the HCHS/SOL Central Labora-
tory for assays and long-term storage. HDL
cholesterol (HDL-C) was measured by a
magnesium/dextran sulfate method, and
plasma glucose was measured using a
hexokinase enzymatic method (Roche
Diagnostics, Indianapolis, IN). Triglycer-
ides were measured in serum on a
Roche Modular P chemistry analyzer,
using a glycerol blanking enzymatic
method (Roche Diagnostics). The assay
methodologies and their performance
are described in HCHS/SOL Manual
7 (Addendum; at http://www.cscc.unc
.edu/hchs/public/docfilter.php?study=
hchs&filter_type=public).
Participants were asked to bring all
prescription and nonprescription medi-
cations and supplements taken during
the preceding 4 weeks to the examina-
tion, where all preparations, and their
concentrations and units were coded.
Interviewer-administered question-
naires were used to obtain information
on demographic factors, education and
income, country of origin and genera-
tional status, length of residence in the
U.S., and language preference.
The metabolic syndrome was defined
according to the American Heart Asso-
ciation/ National Heart, Lung, and Blood
Institute 2009 Joint Scientific Statement
(7), namely, subjects had to have three
or more of the following criteria: 1)
waist circumference $102 cm in men
and $88 cm in women; 2) triglyceride
level $150 mg/dL; 3) HDL-C level ,40
mg/dL in men and,50mg/dL in women;
4) blood pressure $130 mmHg systolic
and/or $85 mmHg diastolic, and/or the
subject was receiving medication; and 5)
fasting glucose level$100 mg/dL and/or
the subject was receiving medication.
Statistical Analysis
Summary statistics and their variances
were weighted to adjust for sampling
probability and nonresponse (9). Means,
medians, and prevalence estimates were
computed by sex and Hispanic/Latino
background, and were age-standardized
to the year 2010 U.S. population. The
frequency of the component abnormal-
ities of the metabolic syndrome also
was determined. All statistical tests
were two-sided at a significance level
of 0.05. Analyses were performed using
SAS version 9.2 (SAS Institute) and
SUDAAN release 10.0.0 (RTI).
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RESULTS
Of the 39,384 sampled individuals who
met eligibility criteria and were se-
lected, 41.7% enrolled in the study. Af-
ter the exclusion of individuals with
missing/underreported Hispanic back-
ground (n = 81) or missing covariates
(n = 48), 9,789 women and 6,530 men
were available for these analyses. As
shown in Table 1, the mean baseline
age was 41.1 years and was comparable
for all Hispanic/Latino groups. Individu-
als of Mexican origin represented close
to 40% of all sampled individuals,
followed by those of Puerto Rican
(17%), Cuban (14%), Central American
(11%), Dominican (9%), and South
American (7%) origin. Consistent with
national surveys (10), 77% of the
HCHS/SOL participants were over-
weight (BMI 25–29.9 kg/m2) or obese
(BMI $30 kg/m2).
Approximately 77% of the partici-
pants were not born in the U.S. Al-
though 57% of the participants had
lived in the U.S. .15 years, 75%
indicated a preference for conducting
the interviews in Spanish. About 32%
of the participants had less than a high
school education, 28% had completed
high school, and 38% had more than a
high school education. Educational
achievement did not differ by Hispanic
background.
The age-standardized prevalence of
the metabolic syndrome was 33.7%
(95% CI 32.2–35.2%) in men and 36.0%
(95% CI 34.6–37.4%) in women (Table
2). The prevalence of the metabolic syn-
drome increased steadily with age
overall and in both men and women,
although a greater increase with age
was seen in women (P value for interac-
tion 0.004). Variability in the prevalence
of the metabolic syndrome was seen by
Hispanic/Latino background and by sex
(Table 2). The overall prevalence of the
metabolic syndrome was highest among
Puerto Ricans (37%, not statistically sig-
nificantly different from other groups
among the men), and significantly (P ,
0.05) lower among South Americans
(27%) compared with other Hispanic/
Latino backgroundsoverall and inwomen.
The prevalence of the metabolic syn-
drome was significantly (P , 0.005)
higher in Puerto Rican women compared
with Puerto Rican men.
Figure 1 displays the prevalence of
the number of individual cardiometa-
bolic abnormalities of the metabolic
syndrome by sex and Hispanic/Latino
background. Overall, South Americans
and Dominicans had the lowest preva-
lence of individual abnormalities (and
thus of the metabolic syndrome).
Puerto Rican women had a higher bur-
den of metabolic abnormalities com-
pared with Puerto Rican men and with
women of other Hispanic/Latino back-
ground groups (Fig. 1). South American
men had the lowest prevalence of met-
abolic syndrome abnormalities. Among
women, the prevalence of zero, one,
two, three, four, and five cardiometa-
bolic abnormalities was 13.5%, 23.3%,
27.3%, 19.9%, 11.3%, and 4.6%, respec-
tively. The corresponding prevalences
among men were 20.7%, 22.9%, 22.9%,
19.6%, 10.0%, and 3.8%, respectively.
A characteristic common to both
sexes is the strong association between
the number of cardiometabolic abnor-
malities and age. The prevalence of
(all) five cardiometabolic abnormalities
was 0.2% in women 18–29 years of age,
10% in women 60–69 years of age, and
14% in women 70–74 years of age. Con-
versely, the prevalence of zero cardio-
metabolic abnormalities was 27% in
women 18–29 years of age, 2% in
women 60–69 years of age, and 0.5%
in women 70–74 years of age. This pat-
tern was comparable in men in that the
prevalence of the five cardiometabolic
abnormalities was 0.8% in men 18–29
years of age, 8% in men 60–69 years of
age, and 10% inmen 70–74 years of age.
However, unlike women, the prevalence
of zero cardiometabolic abnormalities
was 43% in men 18–29 years of age,
6% in men 60–69 years of age, and 8%
in men 70–74 years of age.
The profile of the cardiometabolic ab-
normalities among Hispanic/Latinos dif-
fered by sex. The most prevalent
component of the metabolic syndrome
in women was abdominal obesity irre-
spective of age group (Supplementary
Table 1). Among women, the prevalence
of low HDL-C level was higher in those
18–44 years of age, whereas the preva-
lences of elevated blood pressure and
hyperglycemia were higher in those
75–74 years of age. Prevalences were
higher for hypertriglyceridemia and
low HDL-C level in men 18–44 years of
age, whereas prevalences were higher
Table 1—Characteristics of the 16,319 HCHS/SOL study participants included in
this report (HCHS/SOL baseline examination, 2008–2011)
Characteristics Values
Age, years (mean) (SE) 41.1 (0.25)
Women (%) 52.2 6 0.6
Hispanic/Latino background, N (%)*
Dominican 1,457 (8.9)
Central American 1,725 (10.5)
Cuban 2,343 (14.3)
Mexican 6,451 (39.3)
Puerto Rican 2,702 (16.5)
South American 1,063 (6.5)
Mixed/other 497 (3.0)
BMI (%)†
Underweight/normal (,25 kg/m2) 23.1 6 0.5
Overweight (25–29.9 kg/m2) 37.1 6 0.6
Obese ($30 kg/m2) 39.6 6 0.7
Missing information 0.2 6 0.05
Years in the U.S. .15 years (%) 57.0 6 1.1
Not born in the 50 U.S. states (%) 77.3 6 0.8
Preference for Spanish (%) 74.9 6 0.9
Education (%)
,High school 31.9 6 0.7
High school 27.9 6 0.6
.High school 38.4 6 0.8
Missing information 1.8 6 0.1
Data are N (%) or %6 SE, unless otherwise indicated. *Unweighted proportions; all other values
displayed in this report are weighted for survey design and nonresponse. †A total of 248 men
(3.7%) and 732 women (7.4%) had BMI values .40 kg/m2. A total of 130 individuals had BMI
values ,18.5 kg/m2 (,1%).
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for e levated blood pressure and
hyperglycemia in men 45–64 and
75–74 years of age (Supplementary
Table 2). The degree to which the me-
dian value of an individual risk factor
was elevated relative to the threshold
was greater with increasing age and
with the number of risk factors, in men
and in women (Supplementary Tables 1
and 2).
Among participants with the meta-
bolic syndrome, 73% of the men and
96% of the women had abdominal obe-
sity (exceeding waist circumference
thresholds of 102 and 88 cm, respec-
tively); 73% of men and 59% of women
had hypertriglyceridemia; 67% of men
and 75% of women had low HDL-C lev-
els; 66% of men and 64% of women had
elevated blood pressure or were receiv-
ing antihypertensive treatment; and
73% of men and 62% of women had hy-
perglycemia or were receiving hypogly-
cemic agents. Low HDL-C values were
remarkably common in women 18–44
years of age with the metabolic syn-
drome, while both elevated triglyceride
levels and low HDL-C levels were higher
among the men with metabolic syn-
drome who were .65 years of age.
Some variability in the prevalence of in-
dividual cardiometabolic abnormalities
across Hispanic/Latino backgrounds
was observed (Fig. 2). Among men
with themetabolic syndrome, Dominicans
had the lowest prevalence of low HDL-C
compared with men of other Hispanic/
Latino backgrounds, except Puerto
Ricans. Among women with the meta-
bolic syndrome, the prevalence of
abdominal adiposity was high regard-
less of Hispanic/Latino background.
Dominican women had the lowest
prevalence of hypertriglyceridemia
compared with other Hispanic/Latino
backgrounds. Mexican women had the
highest prevalence of hypertriglyceride-
mia compared with women of other
Hispanic/Latino backgrounds, except
for South Americans, and had the low-
est prevalence of elevated blood pres-
sure compared with women of other
Hispanic/Latino backgrounds.
CONCLUSIONS
Hispanics/Latinos, who are the largest
U.S. minority group, experience a high
burden of cardiovascular risk factors
(11). Obesity, the metabolic syndrome,
and diabetes have been found to
be prevalent in Latinos/Hispanics at
alarming rates, but limitations in the
available data, combined with public
health concerns led to recommen-
dations for additional research in
Hispanics/Latinos to understand the
risk profile of this population (12). We
add to this body of information by
describing the prevalence of metabolic
syndrome in its harmonized definition
(7) among U.S. Hispanic/Latino adults
of diverse backgrounds.
The prevalence of the metabolic syn-
drome in the population sampled by the
HCHS/SOL was 34% in men and 36% in
women, which is comparable to reports
based on national probability samples
indicating a higher frequency of occur-
rence in U.S. Hispanics than in whites
(10,13). Among HCHS/SOL participants,
21% of men and 14% of women had no
cardiometabolic abnormalities, 34% of
men and 36% of women had three or
more cardiometabolic abnormalities,
and 3.8% of men and 4.6% of women
had five or more abnormalities.
The remarkable features in these data
are the high proportion of women who
meet the metabolic syndrome criterion
of three or more factors in each age
stratum by virtue of exceeding the
threshold value for abdominal girth,
the high median values of waist circum-
ference observed, and the progressively
larger increments in median waist val-
ues across increasing numbers of risk
factors present. This suggests that ab-
dominal adiposity is the salient contrib-
utor to the metabolic syndrome among
the women in the HCHS/SOL, to a
greater degree than, for example, ele-
vated blood pressure or the impair-
ments in lipid or glucose metabolism
that are often associated with the for-
mer. A limitation of these data is the low
response at the level of the sampled
households, which was 33.5%. All esti-
mates are adjusted for nonresponse (9).
As is the case for much of the existing
research on the health status of His-
panic/Latino groups in the U.S., most
previous reports on the metabolic syn-
drome among Hispanics are based on
Mexican Americans or a pooled hetero-
geneous group of Hispanics/Latinos. Al-
though limited by small numbers, a prior
report (14) identified heterogeneity in
the frequency of the metabolic syn-
drome and its components in women
by Hispanic/Latino background. As also
observed among the women in the
HCHS/SOL, the prevalence of metabolic
syndrome in the New Jersey site of
the Study of Women’s Health Across
the Nation was greatest in Puerto Rican
women (48%) and was lowest in Domini-
can women at this Study of Women’s
Health Across the Nation site (13%), al-
though the SEs for these estimates were
rather large. Similar patterns were ob-
served in the Multi-Ethnic Study of Ath-
erosclerosis, in that Dominicanmen and
Table 2—Age-standardized prevalence of the metabolic syndrome by Hispanic/








Overall 35.0 (34.0–36.1) 33.7 (32.2–35.2) 36.0 (34.6–37.4)
Hispanic/Latino background
Dominican (n = 1,457) 31.5 (29.0–34.0) 30.6 (26.3–35.2) 32.2 (28.9–35.8)
Central American (n = 1,725) 35.8 (33.0–38.7) 32.6 (28.5–36.9) 37.7 (34.7–40.8)
Cuban (n = 2,343) 34.8 (32.6–37.0) 34.7 (31.9–37.6) 34.9 (32.0–37.9)
Mexican (n = 6,451) 35.0 (33.2–36.9) 33.7 (31.3–36.2) 36.0 (33.5–38.6)
Puerto Rican (n = 2,702) 37.1 (34.4–39.9) 32.6 (28.7–36.8) 40.9 (37.4–44.6)*
South American (n = 1,063) 27.3 (24.2–30.7)† 27.0 (22.3–32.4) 26.8 (23.1–30.9)‡
Age-groups (years)
18–29 (n = 2,644) 12.7 (11.1–14.4) 12.9 (10.8–15.3) 12.4 (10.3–14.9)
30–39 (n = 2,375) 24.7 (22.5–27.1) 27.1 (23.6–30.9) 22.4 (19.5–25.7)
40–49 (n = 4,194) 36.7 (34.5–39.0) 36.1 (32.9–39.4) 37.3 (34.5–40.1)
50–59 (n = 4,323) 48.6 (45.9–51.4) 44.8 (41.3–48.4) 51.6 (48.2–55.1)
60–69 (n = 2,283) 56.8 (53.8–59.8) 52.3 (47.7–56.9) 60.6 (56.3–64.7)
70–74 (n = 500) 66.6 (60.3–72.3) 58.0 (49.6–65.9) 72.0 (63.5–79.3)
Data are % (95% CI). Values were weighted for survey design and nonresponse, and were
age-standardized to the population described by the 2010 U.S. Census. *Statistically significant
differences (P, 0.05) were seen between sexes. †Statistically significant differences (P, 0.05)
were seen among Hispanic/Latino backgrounds overall. ‡Statistically significant differences
(P , 0.05) were seen among women.
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women had a lower prevalence of
the metabolic syndrome than Puerto
Ricans (15).
The Cardiovascular Risk Factor Mul-
tiple Evaluation in Latin America
(CARMELA) study (16) compared the
prevalence of the metabolic syndrome
in residents 25–64 years of age (average
age 456 11 years) in seven Latin Amer-
ican cities between 2003 and 2005
(;1,600 examinees per city). The prev-
alence of the metabolic syndrome de-
fined according to the Adult Treatment
Panel III criteria, age- and sex-adjusted
to the sample from each city, ranged
from 14% in Quito, Ecuador, to 27% in
Mexico City, Mexico. For comparison,
use of the Adult Treatment Panel III
criteria in the 2003–2006 NHANES
showed a prevalence of 33% among
Mexican American men and 41% among
Mexican American women (13). Among
the sites surveyed by the CARMELA
study, Mexico City had the highest prev-
alence of obesity (31%), the metabolic
syndrome (27%), and diabetes (9%).
The prevalence of the metabolic syn-
drome observed in the HCHS/SOL (34%
in men and 36% in women) is some-
what higher than that estimated by the
CARMELA study forMexico City, and was
notoriously higher than those observed
in Barquisimeto, Venezuela; Bogota, Co-
lombia; Buenos Aires, Argentina; Lima,
Peru; Quito, Ecuador; and Santiago,
Chile.
Other noteworthy findings from the
HCHS/SOL population are that 96% of
women and 73% of men with the meta-
bolic syndrome had abdominal obesity
using the conventional 102/88 cm
threshold. The International Diabetes
Federation conceived of the metabolic
syndrome based onwaist circumference
thresholds that differ for race and ethnic
groups, and are considerably lower than
those originally used in the National
Cholesterol Education Program criteria.
In its 2012 scientific statement on health
disparities in endocrine disorders (17),
the Endocrine Society called for the
study and adoption of ethnic-specific
cut points for central obesity, to avoid
misclassification and for appropriate
risk management. A number of reports
(18–20) have raised concerns about the
threshold values for waist circumference
used by the current definitions of abdom-
inal obesity, particularly as applied to
Asian, African American, Polynesian,
and Hispanic/Latino populations. The
prevalence of the metabolic syndrome
according to different waist circumfer-
ence thresholds has been published
based on NHANES 2003–2006 data (10).
When less restrictive definitions of
Figure 1—Prevalence (%) of the number of individual cardiometabolic abnormalities in men (A) and women (B) in the HCHS/SOL cohort, by Hispanic/
Latino background. Error bars represent the SE.
care.diabetesjournals.org Heiss and Associates 2395
central obesity were used, prevalence es-
timates increased as expected, whereas
associations with cardiometabolic corre-
lates were not visibly affected.
Recognizing that the risk associated
with a given waist measurement differs
across populations, waist circumference
thresholds recommended for ethnic
Central and South American popula-
tions in the 2009 consensus Joint Scien-
tific Statement (11) are$90 cm for men
and $80 cm for women. Instead, the
data presented in this report are based
on the waist circumference thresholds
familiar to clinical practitioners in the
U.S. ($102 cm in men and $88 cm in
women), and are used as a common
metric in reports from the NHANES
(15). For comparability with studies
based in other countries, we replicated
our analyses using the$90 cm/$80 cm
thresholds for men and women, respec-
tively, recommended by the consensus
Joint Scientific Statement (11) for ethnic
Central and South American popula-
tions (these data are presented in Sup-
plementary Table 3).
There have been several attempts to
establish waist circumference cutoff val-
ues for abdominal obesity suitable to
women in Latin America, drawing on
various criteria such as detection of di-
abetes (21), abnormal carotid artery in-
tima media thickness (22), blood lipid
profile and other risk factors (23), and
hypertension (24). Based on an area of
visceral adipose tissue $100 cm2 mea-
sured by computed tomography scan at
the 5th lumbar vertebra, Aschner et al.
(25) recommended 94 cm for men and
90 cm for women as the threshold of
abdominal obesity. We examined the
impact of waist circumference threshold
values recommended by various au-
thors for Hispanic/Latino populations
on the prevalence of the metabolic syn-
drome in the HCHS/SOL populations.
Overall, their impact on the prevalence
of the metabolic syndrome in women in
the HCHS/SOL was minor. For example,
the use of the 90 cm threshold (instead
of 88 cm), as recommended by Aschner
et al. (25), reduced the prevalence of the
metabolic syndrome in the women of
the HCHS/SOL samples by only 1–2%.
Various names and definitions have
been applied to themetabolic syndrome
since its original description by Reaven
(26) as a cluster of metabolic risk factors
related to insulin resistance. There is
consensus at this time that insulin resis-
tance underlies the clustering of meta-
bolic syndrome abnormalities, and that
Figure 2—Prevalence (%) of individual cardiometabolic abnormalities in men (A) and women (B) with the metabolic syndrome in the HCHS/SOL
cohort, by Hispanic/Latino background. Error bars represent the SE.
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these are associated with an increased
risk of type 2 diabetes and cardiovascu-
lar sequelae (7). Such associations are
well-established for the individual com-
ponents of this syndrome, regardless of
whether they occur in isolation, in com-
bination, or as a qualitatively defined
syndrome based on any three cardio-
metabolic abnormalities. Although the
metabolic syndrome is embedded in
clinical management guidelines, there
is no consensus about the value of the
metabolic syndrome as a tool to screen
for future risk of type 2 diabetes or car-
diovascular diseases. Whether the
cardiometabolic risk factors that con-
stitute the metabolic syndrome occur
alone or in clusters, evidence indicates
that all such risk factors should be ad-
dressed individually, and managed
effectively (27). To our knowledge, no
evidence has been put forward to date
for nonadditivity of these metabolic
factors on the risk of type 2 diabetes,
incident cardiovascular disease, or
mortality (i.e., that the risk associated
with the metabolic syndrome exceeds
the risk conferred by the sum of the
individual cardiometabolic risk factors
that contributes to the syndrome)
(27–29).
To aid in the interpretation of waist
circumference, Lemieux et al. (30) pro-
posed the concurrent measurement of
fasting triglycerides as an inexpensive
means to screen for the atherogenic
metabolic dysregulation triad charac-
terized by hyperinsulinemia, elevated
apolipoprotein B level, and small, dense
LDL-C. In the HCHS/SOL data, fasting
triglyceride levels, HDL-C levels, systolic
blood pressure, and fasting glucose
levels each were associated with waist
circumference in a monotonically in-
creasing (graded) linear fashion, with-
out indications of an inflection point
or a threshold for waist circumference
(data not shown).
As a qualitative approach to the
characterization of cardiometabolic ab-
normalities associatedwith insulin resis-
tance, the metabolic syndrome has
been endorsed by major professional
and scientific organizations (7). Al-
though the Endocrine Society endorsed
the use of the metabolic syndrome in
clinical practice guidelines as a tool
for primary prevention of type 2 diabe-
tes and cardiovascular disease, its rel-
evance still is subject to disagreement
(31). The lack of management or ther-
apies specific to this syndromedas
opposed to its individual component
abnormalitiesdmakes its use in clini-
cal settings counterintuitive, and the
need for sex-, race-, and ethnic group-
specific thresholds for abdominal adi-
posity for a “universal” definition of
the metabolic syndrome makes this
construct susceptible to misclassifica-
tion and remains a source of contro-
versy (25).
The metabolic syndrome traits are
known to have high heritability (30–
70%), and candidate gene approaches,
linkage studies, and genome-wide asso-
ciation studies (32) have identified sus-
ceptibility regions and loci for individual
metabolic syndrome components. The
heritability of the metabolic syndrome
is reportedly 30%, although little of
this heritability has been accounted for
(33). Evidence for a common genetic un-
derpinning of the broad spectrum of the
metabolic syndrome has not been forth-
coming, despite reports from genome-
wide association studies of genetic
variants associated with more than one of
the metabolic abnormalities included in
the metabolic syndrome (34). Although
well-conducted studies failed to identify
significant genetic susceptibility to mul-
tiple metabolic syndrome components
(35), the modulation of metabolic syn-
drome expression by gene 3 environ-
ment interactiondsuch as gene 3
energy expenditure interaction (36)d
warrants further study.
The clustering of metabolic impair-
ments and the observed temporal
trends in the prevalence of the meta-
bolic syndrome are thought to result
from excess food consumption and/or
reduced levels of physical activity. Ex-
cess nutrient intake leads to adiposity
and activation of stress signaling, which
in turn results in chronic activation of
proinflammatory kinase pathways that
desensitize the metabolic response to
insulin (37). Development of the meta-
bolic syndrome in humans is also
thought to be promoted by high levels
of saturated fats, supported by animal
models where high-fat diets induced
metabolic disease (38). Recent work
has highlighted the role of intestinal mi-
crobiota in promoting the cardiometa-
bolic abnormalities associated with the
metabolic syndrome, such as adiposity,
by increasing the capacity of the host to
extract energy from ingested food (39),
or through interaction with the innate
immune system in modulating inflam-
matory signaling (40). Murine models
suggest that the loss of Toll-like receptor
5 function in the intestinal mucosa
changes gut microbiota that induce
low-grade inflammatory signaling,
which may desensitize insulin receptor
signaling, leading to excess food con-
sumption and the associated cardiometa-
bolic abnormalities of the metabolic
syndrome (40). The excess caloric con-
sumption thought to drive the current
epidemic in metabolic syndrome may
therefore be influenced in part by host-
microbiota interactions.
In conclusion, the prevalence of the
metabolic syndrome, and that of the
cardiometabolic abnormalities that are
considered to be components of the
metabolic syndrome, is high in His-
panic/Latinos and varies by sex and
across Hispanic/Latino backgrounds.
Abdominal adiposity predominates in
Hispanic/Latino women; in men, the
characterization by Hispanic/Latino
backgrounds shows heterogeneity in
the profiles of the component cardio-
metabolic abnormalities. The preven-
tion of metabolic abnormalities and
their clinical management may benefit
from awareness of the diversity in car-
diometabolic dysregulation by sex and
Hispanic/Latino background. This is re-
inforced by the lack of prevention poli-
cies or clinical management guidelines
that are specific to the metabolic syn-
drome per se, as opposed to its compo-
nent factors. Efforts to control the
population burden of cardio-metabolic
risk among Hispanics/Latinos will bene-
fit from the observed differences by sex
and Hispanic/Latino backgrounds.
Acknowledgments. The authors thank the
Hispanic Community Health Study/Study of
Latinos (HCHS/SOL) participants, who gener-
ously contributed their time and provided the
study data. The authors also thank the HCHS/
SOL staff members for their dedication and
expertise. A complete list of staff and inves-
tigators was published in the Annals of Epide-
miology 2010;20:642–649 and is also available
on the study website (http://www.cscc.unc
.edu/hchs).
Funding. The Hispanic Community Health
Study/Study of Latinos (HCHS/SOL) was carried
out as a collaborative study supported by
contracts from the National Heart, Lung, and
Blood Institute (NHLBI) to the University of
North Carolina (N01-HC65233), the University
care.diabetesjournals.org Heiss and Associates 2397
of Miami (N01-HC65234), Albert Einstein Col-
lege of Medicine (N01-HC65235), Northwestern
University (N01-HC65236), and San Diego State
University (N01-HC65237). The following insti-
tutes, centers, or offices contribute to the
HCHS/SOL through a transfer of funds to the
NHLBI: National Center on Minority Health and
Health Disparities, the National Institute on
Deafness and Other Communication Disorders,
the National Institute of Dental and Craniofacial
Research, the National Institute of Diabetes and
Digestive and Kidney Diseases, the National
Institute of Neurological Disorders and Stroke,
and the Office of Dietary Supplements.
The funding agency had a role in the design and
conduct of the study; in the collection, analysis,
and interpretation of the data; and in the review
and approval of the manuscript.
Duality of Interest. No potential conflicts of
interest relevant to this article were reported.
Authors Contributions. G.H. researched the
literature, interpreted the data, and organized
and wrote the manuscript. M.L.S., N.S., M.M.L.,
C.C., M.C., R.K., A.G., L.G., L.L., and L.A.-S.
contributed to the interpretation of the data
and to the writing of the manuscript, and were
involved in editing during manuscript prepara-
tion. Y.T. conducted the statistical analyses,
provided comments, and had oversight of the
verification of results. G.H. is the guarantor
of this work and, as such, had full access to all
the data in the study and takes responsibility for
the integrity of the data and the accuracy of the
data analysis.
Prior Presentation. A set of preliminary data
from this study was presented at the Epidemi-
ology and Prevention/Nutrition, Physical Activ-
ity, and Metabolism 2013 Scientific Sessions of
the American Heart Association/American
Stroke Association, New Orleans, LA, 19–22
March 2013.
References
1. Hossain P, Kawar B, El Nahas M. Obesity and
diabetes in the developing worldda growing
challenge. N Engl J Med 2007;356:213–215
2. BeydounMA, Wang Y. Gender-ethnic dispar-
ity in BMI and waist circumference distribution
shifts in US adults. Obesity (Silver Spring) 2009;
17:169–176
3. Olshansky SJ, Passaro DJ, Hershow RC, et al.
A potential decline in life expectancy in the
United States in the 21st century. N Engl J
Med 2005;352:1138–1145
4. Ford ES, Li C, Sattar N. Metabolic syndrome
and incident diabetes: current state of the evi-
dence. Diabetes Care 2008;31:1898–1904
5. Ballantyne CM, Hoogeveen RC, McNeill AM,
et al. Metabolic syndrome risk for cardiovascu-
lar disease and diabetes in the ARIC study. Int J
Obes (Lond) 2008;32(Suppl. 2):S21–S24
6. Lakka HM, Laaksonen DE, Lakka TA, et al. The
metabolic syndrome and total and cardiovascu-
lar disease mortality in middle-aged men. JAMA
2002;288:2709–2716
7. Alberti KG, Eckel RH, Grundy SM, et al.; In-
ternational Diabetes Federation Task Force on
Epidemiology and Prevention; National Heart,
Lung, and Blood Institute; American Heart
Association; World Heart Federation; Interna-
tional Atherosclerosis Society; International As-
sociation for the Study of Obesity. Harmonizing
the metabolic syndrome: a joint interim state-
ment of the International Diabetes Federation
task force on epidemiology and prevention; Na-
tional Heart, Lung, and Blood Institute; Ameri-
can Heart Association; World Heart Federation;
International Atherosclerosis Society; and In-
ternational Association for the Study of Obe-
sity. Circulation 2009;120:1640–1645
8. Ford ES, Giles WH, Dietz WH. Prevalence of
the metabolic syndrome among US adults:
findings from the third National Health and Nu-
trition Examination Survey. JAMA 2002;287:
356–359
9. Lavange LM, Kalsbeek WD, Sorlie PD, et al.
Sample design and cohort selection in the His-
panic Community Health Study/Study of Lati-
nos. Ann Epidemiol 2010;20:642–649
10. Ford ES, Li C, Zhao G. Prevalence and corre-
lates of metabolic syndrome based on a harmo-
nious definition among adults in the US.
J Diabetes 2010;2:180–193
11. Daviglus ML, Talavera GA, Avilés-Santa ML,
et al. Prevalence of major cardiovascular risk
factors and cardiovascular diseases among His-
panic/Latino individuals of diverse backgrounds
in the United States. JAMA 2012;308:1775–
1784
12. Davidson JA, Kannel WB, Lopez-Candales A,
et al. Avoiding the looming Latino/Hispanic car-
diovascular health crisis: a call to action. Ethn
Dis 2007;17:568–573
13. Ervin RB. Prevalence of metabolic syn-
drome among adults 20 years of age and over,
by sex, age, race and ethnicity, and body mass
index: United States, 2003-2006. Natl Health
Stat Rep 2009:1–7
14. Derby CA, Wildman RP, McGinn AP, et al.
Cardiovascular risk factor variation within a His-
panic cohort: SWAN, the Study of Women’s
Health Across the Nation. Ethn Dis 2010;20:
396–402
15. Allison MA, Budoff MJ, Wong ND,
Blumenthal RS, Schreiner PJ, Criqui MH. Prev-
alence of and risk factors for subclinical car-
diovascular disease in selected US Hispanic
ethnic groups: the Multi-Ethnic Study of Ath-
erosclerosis. Am J Epidemiol 2008;167:962–
969
16. Schargrodsky H, Hernández-Hernández R,
Champagne BM, et al.; CARMELA Study Investi-
gators. CARMELA: assessment of cardiovascular
risk in seven Latin American cities. Am J Med
2008;121:58–65
17. Golden SH, Brown A, Cauley JA, et al. Health
disparities in endocrine disorders: biological,
clinical, and nonclinical factorsdan Endocrine
Society scientific statement. J Clin Endocrinol
Metab 2012;97:E1579–E1639
18. Katzmarzyk PT, Bray GA, Greenway FL, et al.
Ethnic-specific BMI and waist circumference
thresholds. Obesity (Silver Spring) 2011;19:
1272–1278
19. Palaniappan LP,Wong EC, Shin JJ, Fortmann
SP, Lauderdale DS. Asian Americans have
greater prevalence of metabolic syndrome de-
spite lower body mass index. Int J Obes (Lond)
2011;35:393–400
20. Sumner AE, Sen S, Ricks M, Frempong BA,
Sebring NG, Kushner H. Determining the waist
circumference in African Americans which best
predicts insulin resistance. Obesity (Silver
Spring) 2008;16:841–846
21. Barbosa PJ, Lessa I, de Almeida Filho N,
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